In addition, it should be mentioned that HCC samples with higher METTL18 in pathologic stage III−IV subgroup had worse prognosis in both OS and DSS (P = 0.005; P = 0.044), demonstrating METTL18 as a prognostic factor in HCC samples with distant metastasis. This evidence concerns the gene METTL18 and hepatocellular carcinoma.